Reporter – US
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Eileen Francis
CHPA’s Regulatory, Scientific & Quality Conference rescheduled for 1-2 September and the Dietary Supplements Regulatory Summit for 16 September. Several spring conferences canceled due to Covid-19 will not be rescheduled, groups say.
Supplement manufacturers should increase vigilance over supply chains after FDA suspends routine facility inspections and certain requirements of its foreign supplier verification program. Firms should verify even their trusted supplier’s next few certificates of analysis and step-up adverse event monitoring.
The Covid-19 pandemic could push food and supplement manufacturers to switch to manufacturing OTC or Rx drugs to help fill public health gaps, says a former deputy director of FDA's Office of Dietary Supplement Programs. Many marketers are well equipped to make OTC drugs, he added in FDLI webinar.
Church & Dwight extends its vitafusion gummy line with supplements for unmet nutrition needs, including skin, immunity, children’s sleep and teen nutrition. The products will launch in broad distribution, following the brand’s recently added Goodness and CBD lines.
Sanofi sells US rights to anti-diarrhea Kaopectate brand to Arcadia Consumer Healthcare, which plans to invest in marketing and innovation behind the brand. Arcadia also markets the Nizoral dandruff shampoo and Fungi-Nail consumer health brands.
UK advertising regulator says an ad catalog retailer claiming a CBD patch could reduce chronic pain, anxiety and diabetes violated advertising codes. The agency says claims including the product penetrated quickly through skin were medicinal and not approved by the UK or EU.